Multifocal Neuropathy Study
A randomized, double-blind, placebo controlled CROSS-OVER study of the effectiveness of immune globulin intravenous (human), 10% (IGIV, 10%) for the treatment of multifocal motor neuropathy
Investigators at the University of Maryland are conducting a study on patients with multifocal motor neuropathy. We are recruiting participants at the Maryland site for a 15 month randomized trial to determine the safety and effectiveness of IGIV, 10% on the muscle weakness caused by MMN.
Patients will be reimbursed for the study and will receive free testing and study drug as part of this trial.
For more information on our studies, please call Ms. Denise Landrum at 410-706-6689 or e-mail her at CLandrum@som.umaryland.edu.
This page was last updated: May 9, 2013